.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Platelet-collagen interactions represent a fundamental phase in the body's response to vascular injury. When the protective endothelial lining breaks, subendothelial collagen becomes exposed to circulating blood. This exposure acts as a primary signal for platelet recruitment. Furthermore, these interactions facilitate the transition from a flowing state to a stable clot. By understanding these pathways, clinicians can better appreciate the nuances of hemostasis and thrombosis.
Several specialized receptors manage these vital interactions on the platelet surface. Glycoprotein VI (GPVI) stands as the principal signaling receptor. Additionally, the integrins α2β1 and αIIbβ3 contribute to stable adhesion and structural integrity. Moreover, von Willebrand factor (vWF) serves as a critical bridge. It links platelets to collagen fibers, particularly under high-shear conditions in arterial systems.
Beyond the common types, research now highlights collagen types IV, VI, XV, and XVIII. These variants play distinct roles in maintaining the vascular wall. Consequently, targeting these specific pathways offers hope for novel antithrombotic therapies. These new drugs aim to prevent pathological clotting while minimizing the risk of excessive bleeding.
When blood vessels suffer damage, collagen exposure triggers platelet adhesion. This process activates signaling pathways through receptors like GPVI, which leads to aggregate formation and fibrin production.
GPVI is central to collagen-induced platelet activation. Researchers believe that inhibiting this receptor could prevent arterial thrombosis without significantly impairing normal hemostasis or increasing bleeding risks.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
1. Shen R et al. Platelet-Collagen Interactions in Hemostatic Mechanisms. Adv Healthc Mater. 2026 Jun 06. doi: 10.1002/adhm.71326. PMID: 42251479.
2. Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood. 2003;102(2):449-461.
3. Deckmyn H. Platelet adhesion to collagen. ResearchGate. 2020.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
An overview of how platelet-collagen interactions trigger hemostasis via receptors like GPVI and vWF, offering insights for future antithrombotic drug resea...
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
